Loading clinical trials...
Loading clinical trials...
An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children
Conditions
Interventions
acyclovir/hydrocortisone cream
Locations
10
United States
MCS Clinical Trials
Los Angeles, California, United States
Sunshine Research Center
Opa-locka, Florida, United States
Altus Rsearch,INC
West Palm Beach, Florida, United States
Provident Clincal Research
Addison, Illinois, United States
Central Kentucky Research
Lexington, Kentucky, United States
Rochester Clinical Research
Rochester, New York, United States
Start Date
March 1, 2012
Primary Completion Date
December 1, 2012
Completion Date
February 1, 2013
Last Updated
May 22, 2014
NCT02965781
NCT03977792
NCT00306293
NCT03310294
NCT03307772
NCT02207881
Lead Sponsor
Meda Pharmaceuticals
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions